China plans to add more drugs to price-slashing bulk-buy program - (This is Money via NewsPoints Desk)

  • China will add more drugs to its centralised procurement program as the country looks to curtail high drug prices, as reported by This is Money.

  • According to a meeting chaired by Premier Li Keqiang, generic versions will be prioritised for inclusion in the bulk-buying program.

  • Drugs on the list so far include off-patent cancer treatment pemetrexed, marketed by Eli Lilly under the name Alimta, as well as the leukemia drug imatinib, which is sold by Novartis as Gleevec. 

  • The move has caused the price of some medicines to drop more than 90%, according to the news source.

To read more NewsPoints articles, click here.